Objective Capital Management’s Amgen AMGN Stock Holding History

Objective Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Buy	+562	New	+$192K	0.18%	96
2025 Q1	–	Sell	-1,098	Closed	-$286K	–	80
2024 Q4	$286K	Sell	1,098 -277	-20%	-$82.2K	0.19%	105
2024 Q3	$443K	Buy	+1,375	New	+$450K	0.26%	85
2024 Q1	$241K	Buy	848 +9	+1%	+$2.63K	0.16%	118
2023 Q4	$242K	Buy	839 +1	+0.1%	+$272	0.18%	102
2023 Q3	$225K	Buy	+838	New	+$209K	0.2%	91
2023 Q2	–	Sell	-871	Closed	-$211K	–	99
2023 Q1	$211K	Buy	+871	New	+$214K	0.19%	91

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Objective Capital Management's AMGN Position: Q2 2026 in Review

Objective Capital Management opened a new position in Amgen (AMGN) in Q2 2026: 562 shares worth $204K. The stake represents 0.18% of the portfolio and ranks #96 among its holdings. This is a return to the name: Objective Capital Management previously reported a position in AMGN as recently as Q4 2024.

Objective Capital Management first reported a position in AMGN in Q1 2023 and has held it in 7 quarters since. The position peaked at $443K in Q3 2024. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Objective Capital Management held 562 shares of Amgen worth $204K as of Q2 2026.
Amgen was a new Objective Capital Management position in Q2 2026.
Amgen made up 0.18% of Objective Capital Management's portfolio in Q2 2026, its #96 holding.
Objective Capital Management first reported a position in Amgen in Q1 2023 and has held it in 7 quarters since.
Objective Capital Management's Amgen position peaked at $443K in Q3 2024.
3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Objective Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.